Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Kevin Hughes
Dana Farber Cancer Inst, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Hughes Risk Apps
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Hughes is a co-founder of Hughes Risk Apps, LLC. The company provides software which takes patient entered data, runs clinical guidelines, creates risk queues, and supports detailed clinical follow-up on these high risk patients. The co-chairs of Partners Healthcare Committee on Outside Activities evaluated the financial interest in connection with this research and determined that, based on the close connection between the company's interest and the research, the financial interest could directly and significantly affect the design, conduct or reporting of the research.
Risk assessment in atypical breast hyperplasia
Atypical hyperplasia of the breast ('atypia') is a type of benign breast disease commonly and increasingly found among women, and known to increase the risk of developing malignant forms of breast disease, including invasive breast cancer, later in life. For women diagnosed with atypia, especially if other risk factors such as family history are present, it may be appropriate to consider preventative approaches such as chemoprevention and preventative surgery. Decisions about these procedures are complex. When completed, our research would make available a new, comprehensive and validated approach for risk assessment in women diagnosed with atypia, contributing to a more efficient, targeted and personalized evaluation of preventative approaches for invasive breast cancer; this will both increase patients' awareness of their options and risks, and better support a rational choice between available therapeutic treatments.
Filed on August 17, 2015.
Tell us what you know about Kevin Hughes's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.